Fibrin Degradation Product Kit

Rapidchip D-dimer

We created this page for medical staff.

  • *Read carefully the package insert before use.

Intended Use

D-dimer (D-D dimer) is a fibrin degradation product that is produced when plasmin degrades stabilized fibrin that has been cross-linked by activated factor XIII. The blood contains DD complexes (D-dimers) of various molecular forms, such as YY/DXD, YD/DY, and DD/E.
Because an increase of the blood D-dimer level indicates that a clot has formed in vivo and has undergone fibrinolysis, this marker is known to be useful for diagnosing various diseases such as malignancy, obstetric diseases, vascular disorders, disseminated intravascular coagulation (DIC), deep venous thrombosis (DVT), and pulmonary embolism (PE).

Specification of Rapidchip D-dimer

Drug Classification In Vitro Diagnostics
Certification No. in Japan 225ADAMX00125000
Package Test device 20 pcs.
Accessory: CAL 1 pc.
Storage 2-10℃
Samples Plasma or whole blood
(citrated, heparinized)
Sample Volume 120μL
Measurement Time 10 min
Measurement Range 0.2-15µg/mL
Assay Principle Immunochromatography
Detection Method Reflected light intensity as measured by dedicated instrument

Manufacturer
SEKISUI MEDICAL CO., LTD.
1-3, Nihonbashi 2-chome, Chuo-ku, Tokyo 103-0027 Japan

Sold Separately

Product Name Package Storage
Rapidchip D-dimer Control* 1 × 2conc. × 0.5mL(lyophilized) 2-10℃
  • *Not an in vitro diagnostic product in Japan.

"Rapidpia" and all related logos are trademarks or registered trademarks of SEKISUI MEDICAL CO., LTD. in Japan and/or other countries.
"Rapidchip" is trademark or registered trademark of SEKISUI MEDICAL CO., LTD. in Japan and/or other countries.

POCT(Point of Care Testing) Products List

Analyzer Products List

We prepared this page for medical staff (doctors, dentists, pharmacists, clinical laboratory technicians, nurses, etc.) in Japan to ensure the correct use of our products. You should be aware that the information provided is not intended for overseas medical staff and the general public.